FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

9882211000001100: Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
31781301000001110 Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
31781401000001119 Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet Is pack of Cascara dry extract 130mg / Senna leaf 32mg tablets false Inferred relationship Existential restriction modifier
Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet Has active ingredient Cascara false Inferred relationship Existential restriction modifier
Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet Has active ingredient Senna leaf powdered false Inferred relationship Existential restriction modifier
Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet Has VMP Cascara dry extract 130mg / Senna leaf 32mg tablets true Inferred relationship Existential restriction modifier
Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet Has specific active ingredient Cascara dry extract true Inferred relationship Existential restriction modifier
Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet Has specific active ingredient Senna leaf powdered true Inferred relationship Existential restriction modifier
Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Senncalax tablets (Galpharm International Ltd) 20 tablet 2 x 10 tablets Is a True Cascara dry extract 130mg / Senna leaf 32mg tablets 20 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start